• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2019-04-26 20:57 原文鏈接: ImmunofluorescentStainingofMouseandRatLeukocytes

    I. Procedure

    • Harvest cells from tissue, preparing a single cell suspension. Red blood cells may be removed by lysis or density gradient: Red blood cells from murine peripheral blood or a spleen cell suspension can be lysed using BD Biosciences Pharmingen's PharM Lyse? (Cat. No. 35221E) solution. Add 2.0 ml of 1X Lysing Solution to the spleen cell suspension or per 200 μl of murine peripheral blood. Gently vortex immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 15 min. Centrifuge 200 x g for 5 min. Carefully aspirate and dispose of supernatant, without disturbing the pellet. Resuspend pellet in 1X cold wash buffer (PBS/0.1% NaN3/1.0% fetal bovine serum). Centrifuge at 350 x g for 5 min. Finally, resuspend cell pellet to a concentration of 2 x 107 cells/ml (i.e., 106 cells per 50 μl).

    • Dilute primary mAbs (e.g., unconjugated, biotinylated, or fluorochrome-conjugated mAbs) to predetermined optimal concentrations (see Staining Tips) in wash buffer and deliver to the wells of a U-bottom microtiter plate in a volume of 50 μl.

    • Deliver 106 cells in 50 μl to each well already containing 50 μl of mAb (or 50 μl wash buffer for negative controls). Mix by gently vortexing or tapping.

    • Incubate at 4°C for 20-40 min in the dark.

    • Wash 2X with 200 μl wash buffer (or 3X if a biotin-conjugated primary antibody is used). After each centrifugation, 350 x g for 5 min, aspirate wells or flick plate to remove supernatant. Vortex gently or tap plate to loosen pellet prior to adding next wash or diluted secondary reagent.

    • If a second-step reagent is needed, resuspend cell pellet in 100 μl of appropriately diluted secondary reagent (e.g., fluorochrome-conjugated avidin, streptavidin, anti-Ig allotype, anti-Ig isotype, polyclonal anti-Ig). For example, dilute antibody to ~1 μg per 100 μl in wash buffer and add this to each well containing the loosened cell pellet.

    • Incubate at 4°C for 20-40 min in the dark.

    • Wash 2X with 200 μl wash buffer, as in Step 5. Use 100 μl wash buffer to transfer cell pellets to 0.4 ml aliquots of wash buffer (final concentration ~106 cells in 0.5 ml) in tubes appropriate for flow cytometer. Acquire sample data on flow cytometer as soon as possible after staining. (Please see Staining Tip 5.)

    II. Staining Tips

    • Determine optimal concentrations (brightest staining/lowest background) of each primary and secondary antibody by titrating, in a preliminary experiment, between 1.0 μg and 0.1 μg antibody per 100 μl wash buffer for 106 cells.

    • When performing multi-color labeling, directly-conjugated mAbs can be added simultaneously, rather than sequentially. For instrument set-up, please see description in "Procedure for Setting Compensation for Multi-Color Flow Cytometric Analysis".

    • For reducing FcgII/IIIR-mediated antibody binding (or binding of SAv-PE or SAv-Cy-Chrome) which could contribute to background, the use of anti-mouse CD32/CD16 (Mouse BD Fc Block?; Cat No. 553141/553142) or anti-rat CD32 (Rat BD Fc Block?; Cat. No. 550270/550271) is recommended. BD Fc Block? can be added to cells (~0.25 μg per million cells, 3 - 5 min, 4°C) and need not be washed out prior to addition of primary mAb. It is important to verify that no secondary reagent will bind the BD Fc Block?. Please see description in "The Uses of BD Fc Block? in Immunophenotyping of Mouse and Rat Leukocytes".

    • For very low-density cell surface markers (e.g.,cytokine receptors), a three-step protocol may amplify the staining: use purified primary antibody (steps 2-4 of above procedure), biotinylated anti-Ig for the 2nd step (steps 6-7, above), and fluorochrome-conjugated avidin or streptavidin as the 3rd step (repeat steps 6-7). We find that SAv-PE and SAv-BD Cy-Chrome? are "brighter" than FITC conjugates and may provide even better discrimination of low-density antigens, especially in the presence of BD Fc Block?, for mouse cells. (Please see Staining Tip 3.)

    • We have found that freshly-isolated leukocytes and cell lines may wait for analysis in wash buffer at 4°C, without fixation, for up to 18 hr post-staining, without loss of viability. Activated lymphocytes may lose viability rapidly, and data should be collected within 5 hr post-staining. To preserve cell integrity beyond these time limits, paraformaldehyde fixation may be necessary; however, it is possible that the quality of staining may be diminished by such fixation. We do not recommend fixation of stained cells, except when the possibility of exposure to biohazardous material exists.

    • Every experiment must include controls. Negative controls are samples` of the same cell population treated exactly as the test sample, but with the omission or modification of one of the staining steps. Examples of negative controls are unstained cells, cells exposed to the 2nd step reagent alone, or cells exposed to isotype controls which are the same isotype and format (e.g.,purified, biotin or fluorochrome) as the primary antibody and titrated in parallel. For multi-color staining, single-color stained controls should be included. To identify markers on an unknown or novel cell type, positive controls (i.e., cells which are known to express the antigen of interest) should be included in each experiment and should be handled exactly as the test samples.


    相關文章

    科學家將人工智能技術成功用于蛋白質復合物結構預測

    蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......

    發力癌癥分子病理診斷,無錫臻和全資收購TissueofOrigin?

    2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......

    這3個雜志撤回中國學者249篇文章,包含上交、中山等名校

    2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    腫瘤治療的強心劑,中國學者開發腫瘤治療新策略

    磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......

    llumina宣布推出新型基因分型芯片|支持AllofUs研究計劃

    2018年12月6日,來自圣迭戈的消息——Illumina公司(納斯達克股票代碼:ILMN)今天宣布推出新型高密度基因分型芯片Infinium?GlobalDiversityArray。這款芯片設計源......

    SDSPAGE異常電泳現象及分析SDSPAGEHallofShame

    SDS-PAGE異常電泳現象及分析SDS-PAGEHallofShame.pdf  很不錯的東東~~推薦下~......

    Preparationofdenaturing6%

    Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频